Global PD-L1 Biomarker Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 34643
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The PD-L1 Biomarker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global PD-L1 Biomarker Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 42.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 2859.9 million by 2025, from USD 700.3 million in 2019.

Market segmentation

PD-L1 Biomarker Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, PD-L1 Biomarker Testing market has been segmented into:

PD-L1 (22C3)

PD-L1(28-8)

PD-L1 (SP142)

PD-L1 (SP263)

Other

By Application, PD-L1 Biomarker Testing has been segmented into:

Hospital

Diagnostic Center

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global PD-L1 Biomarker Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level PD-L1 Biomarker Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PD-L1 Biomarker Testing market.

The report offers in-depth assessment of the growth and other aspects of the PD-L1 Biomarker Testing market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and PD-L1 Biomarker Testing Market Share Analysis

PD-L1 Biomarker Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PD-L1 Biomarker Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PD-L1 Biomarker Testing sales, revenue and market share for each player covered in this report.

The major players covered in PD-L1 Biomarker Testing are:

Agilent Technologies

Innovent

Bristol-Myers Squibb

Roche

Regeneron

Merck

Junshi Biosciences

Ono Pharmaceutical

AstraZeneca

Hengrui Medicine

Among other players domestic and global, PD-L1 Biomarker Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 PD-L1 Biomarker Testing Market Overview

1.1 Product Overview and Scope of PD-L1 Biomarker Testing

1.2 Classification of PD-L1 Biomarker Testing by Type

1.2.1 Global PD-L1 Biomarker Testing Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global PD-L1 Biomarker Testing Revenue Market Share by Type in 2019

1.2.3 PD-L1 (22C3)

1.2.4 PD-L1(28-8)

1.2.5 PD-L1 (SP142)

1.2.6 PD-L1 (SP263)

1.2.7 Other

1.3 Global PD-L1 Biomarker Testing Market by Application

1.3.1 Overview: Global PD-L1 Biomarker Testing Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Global PD-L1 Biomarker Testing Market by Regions

1.4.1 Global PD-L1 Biomarker Testing Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of PD-L1 Biomarker Testing (2015-2025)

1.4.3 North America (USA, Canada and Mexico) PD-L1 Biomarker Testing Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) PD-L1 Biomarker Testing Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PD-L1 Biomarker Testing Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) PD-L1 Biomarker Testing Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PD-L1 Biomarker Testing Status and Prospect (2015-2025)

2 Company Profiles

2.1 Agilent Technologies

2.1.1 Agilent Technologies Details

2.1.2 Agilent Technologies Major Business

2.1.3 Agilent Technologies SWOT Analysis

2.1.4 Agilent Technologies Product and Services

2.1.5 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.2 Innovent

2.2.1 Innovent Details

2.2.2 Innovent Major Business

2.2.3 Innovent SWOT Analysis

2.2.4 Innovent Product and Services

2.2.5 Innovent PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.3 Bristol-Myers Squibb

2.3.1 Bristol-Myers Squibb Details

2.3.2 Bristol-Myers Squibb Major Business

2.3.3 Bristol-Myers Squibb SWOT Analysis

2.3.4 Bristol-Myers Squibb Product and Services

2.3.5 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche SWOT Analysis

2.4.4 Roche Product and Services

2.4.5 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.5 Regeneron

2.5.1 Regeneron Details

2.5.2 Regeneron Major Business

2.5.3 Regeneron SWOT Analysis

2.5.4 Regeneron Product and Services

2.5.5 Regeneron PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.6 Merck

2.6.1 Merck Details

2.6.2 Merck Major Business

2.6.3 Merck Product and Services

2.6.4 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.7 Junshi Biosciences

2.7.1 Junshi Biosciences Details

2.7.2 Junshi Biosciences Major Business

2.7.3 Junshi Biosciences Product and Services

2.7.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.8 Ono Pharmaceutical

2.8.1 Ono Pharmaceutical Details

2.8.2 Ono Pharmaceutical Major Business

2.8.3 Ono Pharmaceutical Product and Services

2.8.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.9 AstraZeneca

2.9.1 AstraZeneca Details

2.9.2 AstraZeneca Major Business

2.9.3 AstraZeneca Product and Services

2.9.4 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

2.10 Hengrui Medicine

2.10.1 Hengrui Medicine Details

2.10.2 Hengrui Medicine Major Business

2.10.3 Hengrui Medicine Product and Services

2.10.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global PD-L1 Biomarker Testing Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 PD-L1 Biomarker Testing Players Market Share

3.2.2 Top 10 PD-L1 Biomarker Testing Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global PD-L1 Biomarker Testing Revenue and Market Share by Regions

4.2 North America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

4.3 Europe PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

4.5 South America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

5 North America PD-L1 Biomarker Testing Revenue by Countries

5.1 North America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

5.2 USA PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

5.3 Canada PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

5.4 Mexico PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

6 Europe PD-L1 Biomarker Testing Revenue by Countries

6.1 Europe PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

6.2 Germany PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

6.3 UK PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

6.4 France PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

6.5 Russia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

6.6 Italy PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

7 Asia-Pacific PD-L1 Biomarker Testing Revenue by Countries

7.1 Asia-Pacific PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

7.2 China PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

7.3 Japan PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

7.4 Korea PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

7.5 India PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

8 South America PD-L1 Biomarker Testing Revenue by Countries

8.1 South America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

8.2 Brazil PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

8.3 Argentina PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue PD-L1 Biomarker Testing by Countries

9.1 Middle East & Africa PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

9.2 Saudi Arabia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

9.3 UAE PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

9.4 Egypt PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

9.5 South Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global PD-L1 Biomarker Testing Revenue and Market Share by Type (2015-2020)

10.2 Global PD-L1 Biomarker Testing Market Forecast by Type (2019-2024)

10.3 PD-L1 (22C3) Revenue Growth Rate (2015-2025)

10.4 PD-L1(28-8) Revenue Growth Rate (2015-2025)

10.5 PD-L1 (SP142) Revenue Growth Rate (2015-2025)

10.6 PD-L1 (SP263) Revenue Growth Rate (2015-2025)

10.7 Other Revenue Growth Rate (2015-2025)

11 Global PD-L1 Biomarker Testing Market Segment by Application

11.1 Global PD-L1 Biomarker Testing Revenue Market Share by Application (2015-2020)

11.2 PD-L1 Biomarker Testing Market Forecast by Application (2019-2024)

11.3 Hospital Revenue Growth (2015-2020)

11.4 Diagnostic Center Revenue Growth (2015-2020)

11.5 Others Revenue Growth (2015-2020)

12 Global PD-L1 Biomarker Testing Market Size Forecast (2021-2025)

12.1 Global PD-L1 Biomarker Testing Market Size Forecast (2021-2025)

12.2 Global PD-L1 Biomarker Testing Market Forecast by Regions (2021-2025)

12.3 North America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

12.4 Europe PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

12.6 South America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global PD-L1 Biomarker Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global PD-L1 Biomarker Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market PD-L1 Biomarker Testing Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global PD-L1 Biomarker Testing Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Agilent Technologies Corporate Information, Location and Competitors

Table 7. Agilent Technologies PD-L1 Biomarker Testing Major Business

Table 8. Agilent Technologies PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 9. Agilent Technologies SWOT Analysis

Table 10. Agilent Technologies PD-L1 Biomarker Testing Product and Solutions

Table 11. Agilent Technologies PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Innovent Corporate Information, Location and Competitors

Table 13. Innovent PD-L1 Biomarker Testing Major Business

Table 14. Innovent PD-L1 Biomarker Testing Total Revenue (USD Million) (2018-2019)

Table 15. Innovent SWOT Analysis

Table 16. Innovent PD-L1 Biomarker Testing Product and Solutions

Table 17. Innovent PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Bristol-Myers Squibb Corporate Information, Location and Competitors

Table 19. Bristol-Myers Squibb PD-L1 Biomarker Testing Major Business

Table 20. Bristol-Myers Squibb PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 21. Bristol-Myers Squibb SWOT Analysis

Table 22. Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions

Table 23. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Roche Corporate Information, Location and Competitors

Table 25. Roche PD-L1 Biomarker Testing Major Business

Table 26. Roche PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 27. Roche SWOT Analysis

Table 28. Roche PD-L1 Biomarker Testing Product and Solutions

Table 29. Roche PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Regeneron Corporate Information, Location and Competitors

Table 31. Regeneron PD-L1 Biomarker Testing Major Business

Table 32. Regeneron PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 33. Regeneron SWOT Analysis

Table 34. Regeneron PD-L1 Biomarker Testing Product and Solutions

Table 35. Regeneron PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Merck Corporate Information, Location and Competitors

Table 37. Merck PD-L1 Biomarker Testing Major Business

Table 38. Merck PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 39. Merck SWOT Analysis

Table 40. Merck PD-L1 Biomarker Testing Product and Solutions

Table 41. Merck PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Junshi Biosciences Corporate Information, Location and Competitors

Table 43. Junshi Biosciences PD-L1 Biomarker Testing Major Business

Table 44. Junshi Biosciences PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 45. Junshi Biosciences SWOT Analysis

Table 46. Junshi Biosciences PD-L1 Biomarker Testing Product and Solutions

Table 47. Junshi Biosciences PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. Ono Pharmaceutical Corporate Information, Location and Competitors

Table 49. Ono Pharmaceutical PD-L1 Biomarker Testing Major Business

Table 50. Ono Pharmaceutical PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 51. Ono Pharmaceutical SWOT Analysis

Table 52. Ono Pharmaceutical PD-L1 Biomarker Testing Product and Solutions

Table 53. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. AstraZeneca Corporate Information, Location and Competitors

Table 55. AstraZeneca PD-L1 Biomarker Testing Major Business

Table 56. AstraZeneca PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 57. AstraZeneca SWOT Analysis

Table 58. AstraZeneca PD-L1 Biomarker Testing Product and Solutions

Table 59. AstraZeneca PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. Hengrui Medicine Corporate Information, Location and Competitors

Table 61. Hengrui Medicine PD-L1 Biomarker Testing Major Business

Table 62. Hengrui Medicine PD-L1 Biomarker Testing Total Revenue (USD Million) (2017-2018)

Table 63. Hengrui Medicine SWOT Analysis

Table 64. Hengrui Medicine PD-L1 Biomarker Testing Product and Solutions

Table 65. Hengrui Medicine PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 66. Global PD-L1 Biomarker Testing Revenue (Million USD) by Players (2015-2020)

Table 67. Global PD-L1 Biomarker Testing Revenue Share by Players (2015-2020)

Table 68. Global PD-L1 Biomarker Testing Revenue (Million USD) by Regions (2015-2020)

Table 69. Global PD-L1 Biomarker Testing Revenue Market Share by Regions (2015-2020)

Table 70. North America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

Table 71. North America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Table 72. Europe PD-L1 Biomarker Testing Revenue (Million USD) by Countries (2015-2020)

Table 73. Asia-Pacific PD-L1 Biomarker Testing Revenue (Million USD) by Countries (2015-2020)

Table 74. South America PD-L1 Biomarker Testing Revenue by Countries (2015-2020)

Table 75. South America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Table 76. Middle East and Africa PD-L1 Biomarker Testing Revenue (Million USD) by Countries (2015-2020)

Table 77. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Table 78. Global PD-L1 Biomarker Testing Revenue (Million USD) by Type (2015-2020)

Table 79. Global PD-L1 Biomarker Testing Revenue Share by Type (2015-2020)

Table 80. Global PD-L1 Biomarker Testing Revenue Forecast by Type (2021-2025)

Table 81. Global PD-L1 Biomarker Testing Revenue by Application (2015-2020)

Table 82. Global PD-L1 Biomarker Testing Revenue Share by Application (2015-2020)

Table 83. Global PD-L1 Biomarker Testing Revenue Forecast by Application (2021-2025)

Table 84. Global PD-L1 Biomarker Testing Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. PD-L1 Biomarker Testing Picture

Figure 2. Global PD-L1 Biomarker Testing Revenue Market Share by Type in 2019

Figure 3. PD-L1 (22C3) Picture

Figure 4. PD-L1(28-8) Picture

Figure 5. PD-L1 (SP142) Picture

Figure 6. PD-L1 (SP263) Picture

Figure 7. Other Picture

Figure 8. PD-L1 Biomarker Testing Revenue Market Share by Application in 2019

Figure 9. Hospital Picture

Figure 10. Diagnostic Center Picture

Figure 11. Others Picture

Figure 12. Global PD-L1 Biomarker Testing Revenue (USD Million) and Growth Rate (2015-2025)

Figure 13. North America PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Europe PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Asia-Pacific PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. South America PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Middle East and Africa PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Global PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. Global PD-L1 Biomarker Testing Revenue Share by Players in 2019

Figure 20. Global Top 5 Players PD-L1 Biomarker Testing Revenue Market Share in 2019

Figure 21. Global Top 10 Players PD-L1 Biomarker Testing Revenue Market Share in 2019

Figure 22. Key Players Market Share Trend

Figure 23. Global PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 24. Global PD-L1 Biomarker Testing Revenue Market Share by Regions (2015-2020)

Figure 25. Global PD-L1 Biomarker Testing Revenue Market Share by Regions in 2018

Figure 26. North America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 27. Europe PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 28. Asia-Pacific PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 29. South America PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 30. Middle East and Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 31. North America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Figure 32. North America PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019

Figure 33. USA PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 34. Canada PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 35. Mexico PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 36. Europe PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Figure 37. Europe PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019

Figure 38. Germany PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 39. UK PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 40. France PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 41. Russia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 42. Italy PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 43. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Figure 44. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019

Figure 45. China PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 46. Japan PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 47. Korea PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 48. India PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 49. Southeast Asia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 50. South America PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Figure 51. South America PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019

Figure 52. Brazil PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 53. Argentina PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 54. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries (2015-2020)

Figure 55. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Share by Countries in 2019

Figure 56. Saudi Arabia PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 57. UAE PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 58. Egypt PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 59. South Africa PD-L1 Biomarker Testing Revenue and Growth Rate (2015-2020)

Figure 60. Global PD-L1 Biomarker Testing Revenue Share by Type (2015-2020)

Figure 61. Global PD-L1 Biomarker Testing Revenue Share by Type in 2019

Figure 62. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2021-2025)

Figure 63. Global PD-L1 (22C3) Revenue Growth Rate (2015-2020)

Figure 64. Global PD-L1(28-8) Revenue Growth Rate (2015-2020)

Figure 65. Global PD-L1 (SP142) Revenue Growth Rate (2015-2020)

Figure 66. Global PD-L1 (SP263) Revenue Growth Rate (2015-2020)

Figure 67. Global Other Revenue Growth Rate (2015-2020)

Figure 68. Global PD-L1 Biomarker Testing Revenue Share by Application (2015-2020)

Figure 69. Global PD-L1 Biomarker Testing Revenue Share by Application in 2019

Figure 70. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2021-2025)

Figure 71. Global Hospital Revenue Growth Rate (2015-2020)

Figure 72. Global Diagnostic Center Revenue Growth Rate (2015-2020)

Figure 73. Global Others Revenue Growth Rate (2015-2020)

Figure 74. Global PD-L1 Biomarker Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 75. Global PD-L1 Biomarker Testing Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 76. Global PD-L1 Biomarker Testing Revenue Market Share Forecast by Regions (2021-2025)

Figure 77. North America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

Figure 78. Europe PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

Figure 79. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

Figure 80. South America PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

Figure 81. Middle East and Africa PD-L1 Biomarker Testing Revenue Market Forecast (2021-2025)

Figure 82. Sales Channel: Direct Channel vs Indirect Channel

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz